What is the appropriate dosing schedule for hydralazine (as needed) and metoprolol succinate (once daily)?

Metoprolol Succinate and Hydralazine Dosing Schedule

Metoprolol succinate should be administered once daily at a scheduled time (not PRN), starting at 12.5-25 mg daily and titrated up to a target of 200 mg daily, while hydralazine must be dosed 3-4 times daily (not PRN) at 25-50 mg per dose, targeting 300 mg total daily in divided doses. 1, 2, 3, 4

Critical Dosing Errors to Correct

Metoprolol Succinate - Once Daily Scheduled Dosing ONLY

The extended-release formulation is specifically designed for once-daily administration and provides consistent beta-1 blockade over 24 hours 3, 5. This is not a PRN medication:

• Initial dose: 12.5-25 mg once daily (use 12.5 mg for NYHA Class III-IV heart failure, 25 mg for Class II or hypertension) 1, 2, 3
• Titration: Double the dose every 2 weeks as tolerated 3
• Target dose: 200 mg once daily 1, 2, 3
• Mean dose achieved in trials: 159 mg total daily 1, 2

The controlled-release mechanism delivers metoprolol at a near-constant rate for approximately 20 hours, independent of food or GI pH, avoiding the peaks and troughs of immediate-release formulations 5. The tablet can be split in half but must be swallowed whole—never crushed or chewed 3.

Hydralazine - Multiple Daily Doses Required (NOT PRN)

Hydralazine has a short half-life and cannot be dosed PRN or once daily. The pharmacokinetics demand frequent dosing:

• Dosing frequency: 3-4 times daily 1, 2, 4
• Initial dose: 25-50 mg per dose (3-4 times daily) 1, 2
• Target dose: 75-100 mg three times daily (total 225-300 mg/day) 1, 2
• Mean dose in trials: ~175 mg total daily 1, 2

Research confirms that once-daily hydralazine is inadequate—the hypotensive effect wanes at 24 hours, particularly in rapid acetylators, with significant differences between peak and trough effects 6. Twice-daily dosing is the minimum acceptable frequency, though 3-4 times daily is preferred for optimal blood pressure control 6.

Clinical Context and Rationale

Why These Schedules Matter for Mortality

Both medications have proven mortality benefits in heart failure when dosed correctly:

• Metoprolol succinate: 34% relative risk reduction in all-cause mortality (NNT = 28 over 12 months) 1, 2
• Hydralazine (with nitrates): 43% relative risk reduction in all-cause mortality (NNT = 25 over 10 months) 1, 2

These benefits were achieved with scheduled, target-dose therapy—not PRN or suboptimal dosing. Trials that evaluated dose-response showed composite event rates were lower with target doses compared to lower doses 2.

Titration Protocol

For metoprolol succinate in heart failure 3:

1. Stabilize diuretics, ACE inhibitors, and digoxin first
2. Start 12.5-25 mg once daily based on NYHA class
3. Double dose every 2 weeks up to 200 mg daily
4. If transient worsening occurs, increase diuretics and temporarily reduce (not discontinue) metoprolol
5. Do not advance dose until heart failure symptoms stabilize
6. If symptomatic bradycardia develops, reduce dose

For hydralazine 4:

1. Start 25-50 mg 3-4 times daily
2. Increase gradually over 3-4 weeks
3. Maximum 300 mg total daily (or 7.5 mg/kg in pediatrics)
4. Administer with food for higher plasma levels 4

Common Pitfalls

• Never use metoprolol succinate PRN—it requires daily scheduled dosing for consistent beta-blockade
• Never dose hydralazine once daily or PRN—the short duration of action necessitates 3-4 times daily dosing
• Do not abruptly discontinue metoprolol—taper over 1-2 weeks to avoid rebound effects 3
• Monitor for acetylator status effects with hydralazine—slow acetylators achieve better blood pressure control but may need dose adjustment 7, 6
• Do not use subtherapeutic doses—clinical trials demonstrated benefits at target doses, not lower maintenance doses 2